Can Wegovy Weaken Your Immune System?

Why this question arises, and what the trials found

GLP-1 receptor agonists work by mimicking a gut hormone that regulates appetite and slows stomach emptying. Nothing in that mechanism directly targets the cells or proteins your immune system relies on. Still, the question comes up often, and it is a reasonable one. Medicines that change how the body processes food, how much you eat, and how rapidly you lose weight will inevitably affect how you feel, and a run of colds or a slow recovery can easily feel like something is "off" with immunity.

The STEP 1 trial, published in the New England Journal of Medicine, randomised 1,961 adults with obesity or overweight and at least one weight-related condition to semaglutide 2.4 mg or placebo over 68 weeks. Immune suppression did not appear in the identified adverse events. The most commonly reported side effects were gastrointestinal (nausea, vomiting, diarrhoea, constipation) particularly in the weeks after starting treatment or after a dose increase, and generally settling with time. Understanding how semaglutide builds in your system can help put those early weeks in context.

Researchers studying GLP-1 medicines have observed effects on inflammatory markers, but these tend to move in a positive direction as body weight falls: lower levels of C-reactive protein and certain pro-inflammatory cytokines, not higher ones. That is consistent with what we know about obesity itself being a state of chronic low-grade inflammation. Losing weight through any route tends to reduce that background inflammation, and if you want to explore how semaglutide interacts with the immune system in greater depth, the research covers some genuinely interesting ground. If you want to understand how Wegovy affects the immune system in more detail, the evidence points in a broadly reassuring direction.

The body changes that can feel immune-related but usually are not

Fatigue, reduced appetite and occasional lightheadedness are real experiences for many people in the first weeks of treatment, and they can feel unsettling. They are also the body adjusting to eating less and, in some cases, to a period of caloric deficit. Nutritional adequacy matters here. When calorie intake falls significantly, getting enough protein, vitamin D, zinc and other nutrients that support normal immune function requires deliberate attention, something a prescriber or registered dietitian can help you plan for.

Dehydration is another factor worth naming plainly. If nausea or diarrhoea is pronounced, fluid and electrolyte losses can leave you feeling run-down in a way that looks a lot like lowered immunity. The NHS medicines information for semaglutide flags dehydration as a reason to contact a healthcare professional if gastrointestinal side effects are severe or prolonged. That advice is practical, not alarming.

People who are curious about whether semaglutide lowers your immune system at a mechanistic level will find the research landscape is genuinely interesting (animal studies have suggested GLP-1 receptors exist on certain immune cells) but human clinical data confirming meaningful immune effects in people taking Wegovy for weight management remain limited. What the trials have not found is suppression.

Infections, vaccinations and what to tell your clinical team

There is no UK clinical guidance advising people on Wegovy to avoid vaccinations or to take additional precautions against infection that would not apply to the general population. Your prescribers and GP should know you are taking semaglutide, and our clinical team notifies your GP as part of the prescribing process, in line with GPhC guidance, one reason that clinical oversight matters throughout treatment, not just at the start.

If you are on Wegovy and notice a pattern of unusually frequent infections, wounds that are slow to heal, or a persistent low-grade fever, mention it. Do not assume it is the medicine and do not assume it is not. A prescriber can look at the full picture. For general questions about treatment, our frequently asked questions cover a wide range of practical topics.

It is also worth knowing that the January 2026 MHRA Drug Safety Update on GLP-1 medicines focused on acute pancreatitis (severe, persistent abdominal pain that may radiate to the back, with or without vomiting) as the safety signal requiring urgent attention, not immune effects. Knowing what to watch for, and what to prioritise, helps you use the medicine safely.

Putting it in perspective before starting treatment

Wegovy is a prescription-only medicine. In the UK that means a qualified prescriber has to assess whether it is right for you before any treatment begins, you can read more about the weight-loss treatment options available and what the assessment involves. At nume, a GPhC-registered Independent Prescriber reads every consultation personally, not a piece of software.

When treatment is approved, your pen arrives by tracked DPD delivery the next working day, in plain unbranded packaging. Starting on the lowest dose (0.25 mg) is standard practice, giving your body time to adjust before any titration. Most people find the GI side effects, if they occur at all, are most noticeable in those first weeks and ease considerably after that. The cost of Wegovy through a private pharmacy is something many people ask about before committing; the Wegovy cost page sets out what to expect and what should be included in any legitimate price.

If you have specific concerns about how Wegovy might interact with a pre-existing condition affecting your immune health (an autoimmune diagnosis, for instance, or a condition treated with genuinely immunosuppressant medicines) that is exactly the kind of thing a prescriber needs to know about at the consultation stage. It may or may not change the picture; that depends on your individual circumstances. Start your free consultation to have those questions reviewed properly.